At the Intersection of Patient-Centricity & Health Equity: Better Outcomes
One of the most consequential shifts I’ve seen during 20 years in the biopharmaceutical industry is happening right now: A combined focus on patient-centricity and health equity is changing how companies approach end-to-end drug development and how we reach patients who’ve historically been left behind. As the child of immigrant parents, who has lived in…